|
|
|
Centre for Innate Immunity & Infectious Disease
2007 Publications
Journal Articles
Brender C, Tannahill GM, Jenkins BJ, Fletcher J, Columbus R, Saris CJ, Ernst M, Nicola NA, Hilton DJ, Alexander WS, Starr R (2007) Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. Blood 110:2528-2536.
Flentjar N, Chu P-Y, Ng AY-N, Johnstone CN, Heath JK, Ernst M, Hertzog PJ, Pritchard MA (2007) TGF-bRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Gastroenterology 132:1410-1419.
Jenkins BJ, Roberts AW, Greenhill CJ, Najdovska M, Lundgren-May T, Robb L, Grail D, Ernst M (2007) Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood 109:2380-2388.
Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ (2007) Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA 104:16239-16244.
Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, Hertzog PJ, Hamilton JA (2007) Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-b. Bone 40:323-336.
O'Leary DA, Noakes PG, Lavidis NA, Kola I, Hertzog PJ, Ristevski S (2007) Targeting of the ETS factor GABPadisrupts neuromuscular junction synaptic function. Mol Cell Biol 27:3470-3480.
Swann JB, Hayakawa Y, Zerafa N, Sheehan KC, Scott B, Schreiber RD, Hertzog P, Smyth MJ (2007) Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J Immunol 178:7540-7549.
Wilson TJ, Lacham-Kaplan O, Gould J, Holloway A, Bertoncello I, Hertzog PJ, Trounson A (2007) Comparison of mice born after intracytoplasmic sperm injection with in vitro fertilization and natural mating. Mol Reprod Dev 74:512-519.
Reviews
de Weerd NA, Samarajiwa SA, Hertzog PJ (2007) Type I interferon receptors: biochemistry and biological functions. J Biol Chem 282:20053-20057.
Lang T, Mansell A (2007) The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 85:425-434.
Noppert SJ, Fitzgerald KA, Hertzog PJ (2007) The role of type I interferons in TLR responses. Immunol Cell Biol 85:446-457.
Verstak B, Hertzog P, Mansell A (2007) Toll-like receptor signalling and the clinical benefits that lie within. Inflamm Res 56:1-10.
Book Chapters
Wilson TJ, Truman D, Giudice A, Hertzog PJ (2007) Rapid generation of gene targeting constructs by PCR. In PCR-Methods Express. Hughes S, Moody A, eds. Bloxham, Oxfordshire, UK: Scion Publishing. pp 173-196.
|
|
|